78/100 B+ · Low risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

CENTRALESUPELEC

Active 7383 8542 Active for 11 years

7383 · RC 130020761 · Active since 2015

B+

Overview

CENTRALESUPELEC is a 7383 registered , France, since 2015. The company operates in the 8542 sector. Its TraceComp score of 78 (B+) indicates solid fundamentals and low apparent risk. With 11 years of operations, the company has an established track record in its market.

Company Information

Registration Number
130020761
Legal Form
7383
Registered
2015-01-01

Officers & Management

No officers on record.

Public Contracts Won

Awarded 2 public-sector contracts totalling EUR 417,296 (DECP).

Which public buyers, contract titles, values and award dates.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

EU Funding

Direct EU-budget recipient. Received €6,840,525 in direct EU funding (grants and/or contracts from the EU budget).

Source: EU Financial Transparency System (FTS). Cumulative contracted amount across years on record.

Patent Portfolio

Active patent holder. 18 patents · 18 active · 18 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • No financial filings on record — score derives from registry signals and sector context

Data Sources & Freshness

Data sourced from: bulk register.